Human pharmacokinetics and modeling of the concentration-attenuation relationship of a new liposomal liver-specific contrast agent for CT

Acad Radiol. 1998 Apr:5 Suppl 1:S47-8; discussion S60-2. doi: 10.1016/s1076-6332(98)80056-1.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • Contrast Media / administration & dosage*
  • Contrast Media / pharmacokinetics*
  • Female
  • Humans
  • Liposomes / administration & dosage*
  • Male
  • Models, Theoretical
  • Single-Blind Method
  • Tomography, X-Ray Computed*
  • Triiodobenzoic Acids / administration & dosage*
  • Triiodobenzoic Acids / pharmacokinetics*

Substances

  • Contrast Media
  • Liposomes
  • Triiodobenzoic Acids
  • iodixanol